GetTopicDetailResponse(id=3d83125656f5, topicName=復(fù)發(fā)性FSGS, introduction=, content=腎移植 復(fù)發(fā)性FSGS, image=null, comments=0, allHits=252, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Apr 01 09:47:09 CST 2025, time=2025-04-01, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503094, tagList=[TagDto(tagId=503094, tagName=復(fù)發(fā)性FSGS)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2264614, encodeId=dd8f2264614b5, content=<a href='/topic/show?id=8dcb826216c' target=_blank style='color:#2F92EE;'>#腎移植后#</a> <a href='/topic/show?id=3d83125656f5' target=_blank style='color:#2F92EE;'>#復(fù)發(fā)性FSGS#</a>, objectTitle=Clin Kidney J：皮下Ofatumumab聯(lián)合強化血漿置換可安全誘導(dǎo)復(fù)發(fā)性局灶節(jié)段性腎小球硬化癥完全緩解, objectType=article, longId=875711, objectId=46928e5711bf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250221/1740101200194_8538692.jpg, objectUrl=/article/show_article.do?id=46928e5711bf, replyNumber=0, likeNumber=21, createdTime=2025-05-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=46928e5711bf, moduleTitle=Clin Kidney J：皮下Ofatumumab聯(lián)合強化血漿置換可安全誘導(dǎo)復(fù)發(fā)性局灶節(jié)段性腎小球硬化癥完全緩解, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=46928e5711bf)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2258633, encodeId=c295225863364, content=<a href='/topic/show?id=31c58261992' target=_blank style='color:#2F92EE;'>#腎移植#</a> <a href='/topic/show?id=3d83125656f5' target=_blank style='color:#2F92EE;'>#復(fù)發(fā)性FSGS#</a>, objectTitle=Clin Kidney J：血漿置換治療、利妥昔單抗單藥治療及兩者聯(lián)合方案對腎移植后復(fù)發(fā)性FSGS的療效差異, objectType=article, longId=869945, objectId=eefd869945bc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719494105549_2570354.jpg, objectUrl=/article/show_article.do?id=eefd869945bc, replyNumber=0, likeNumber=42, createdTime=2025-04-01, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eefd869945bc, moduleTitle=Clin Kidney J：血漿置換治療、利妥昔單抗單藥治療及兩者聯(lián)合方案對腎移植后復(fù)發(fā)性FSGS的療效差異, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=eefd869945bc)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-04-01
